Skip to content
Catalyst

fructo-oligosaccharidesFinding

Fructo-oligosaccharides has no detected effect on glycated haemoglobin (HbA1c)

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“No significant difference was observed between scFOS and placebo in the change of HbA1c from V2 to V5 (+0.055% vs +0.030%, p = 0.6835) in the ITT population.”
Quoted verbatim from Targeting gut microbiota with short-chain fructo-oligosaccharides prebiotic fibers to support metabolic health in overweight prediabetic adults: a randomized, double-blinded, placebo-controlled study.
This finding among the 64 findings on its endpoint

fructo-oligosaccharides

Glycated haemoglobin (HbA1c)

no difference found

Who
Overweight adults with prediabetes (fasting glycaemia 1 to 1.25 g/L), intention-to-treat population, placebo maltodextrin
Dose studied
20 g/day (two 10 g sachets) for 12 weeks

Moderate evidencePMID 41479657 · 2025

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M71GZJAPNHX5EQDASG4JRVXF